Knights of Columbus Asset Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Sell
2,405
-1,284
-35% -$57.4K 0.01% 360
2026
Q1
$178K Hold
3,689
0.01% 345
2025
Q4
$179K Hold
3,689
0.01% 349
2025
Q3
$174K Buy
3,689
+88
+2% +$4.25K 0.01% 328
2025
Q2
$174K Hold
3,601
0.01% 314
2025
Q1
$200K Sell
3,601
-173
-5% -$9.36K 0.01% 296
2024
Q4
$182K Sell
3,774
-1,184
-24% -$60.2K 0.01% 303
2024
Q3
$286K Buy
4,958
+464
+10% +$25.1K 0.02% 298
2024
Q2
$218K Hold
4,494
0.01% 331
2024
Q1
$218K Sell
4,494
-1,557
-26% -$76K 0.02% 312
2023
Q4
$301K Hold
6,051
0.02% 296
2023
Q3
$325K Buy
6,051
+311
+5% +$16.6K 0.03% 286
2023
Q2
$309K Buy
5,740
+221
+4% +$11.9K 0.03% 296
2023
Q1
$300K Buy
5,519
+1,266
+30% +$61.6K 0.03% 282
2022
Q4
$206K Hold
4,253
0.02% 294
2022
Q3
$162K Buy
4,253
+261
+7% +$11.6K 0.02% 287
2022
Q2
$200K Buy
+3,992
New +$212K 0.02% 276

Other funds holding SNY

Knights of Columbus Asset Advisors's SNY Position: Q2 2026 in Review

Knights of Columbus Asset Advisors reduced its Sanofi (SNY) stake by 35% in Q2 2026, selling an estimated $57.4K and leaving 2,405 shares worth $103K. The position accounts for 0.01% of the portfolio, ranked #360.

Knights of Columbus Asset Advisors first reported a position in SNY in Q2 2022 and has held it in 17 quarters since. The position peaked at $325K in Q3 2023. 404 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Knights of Columbus Asset Advisors held 2,405 shares of Sanofi worth $103K as of Q2 2026.
  • Knights of Columbus Asset Advisors sold 1,284 Sanofi shares in Q2 2026, an estimated $57.4K.
  • Sanofi made up 0.01% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #360 holding.
  • Knights of Columbus Asset Advisors first reported a position in Sanofi in Q2 2022 and has held it in 17 quarters since.
  • Knights of Columbus Asset Advisors's Sanofi position peaked at $325K in Q3 2023.
  • 404 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.